molecular radiotherapy

Open Access
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet Gray, Leona Knox, Kyle B. Matchett, Connie Peet, Katherine A. Vallis, Hugh J. Wallace, Simon Wan and Mark N. Gaze

Journal of Nuclear Medicine April 1, 2025, 66 (4) 490-496; DOI: https://doi.org/10.2967/jnumed.124.269121
You have access
The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation
Andrea K. Miyahira and Howard R. Soule

Journal of Nuclear Medicine March 1, 2022, 63 (3) 331-338; DOI: https://doi.org/10.2967/jnumed.121.262997
You have access
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Jeremie Calais, Andrei Gafita, Matthias Eiber, Wesley R. Armstrong, Jeannine Gartmann, Pan Thin, Kathleen Nguyen, Vincent Lok, Laura Gosa, Tristan Grogan, Rouzbeh Esfandiari, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, David Ranganathan, Roger Slavik, Magnus Dahlbom, Ken Herrmann, Ebrahim Delpassand, Wolfgang P. Fendler and Johannes Czernin

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1440-1446; DOI: https://doi.org/10.2967/jnumed.121.261982
You have access
Safety of PSMA-Targeted Molecular Radioligand Therapy with ¹⁷⁷Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
Jeremie Calais, Johannes Czernin, Pan Thin, Jeannine Gartmann, Kathleen Nguyen, Wesley R. Armstrong, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, Magnus Dahlbom, Beilei He, Rouzbeh Esfandiari, David Ranganathan, Ken Herrmann, Matthias Eiber, Wolfgang P. Fendler and Ebrahim Delpassand

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1447-1456; DOI: https://doi.org/10.2967/jnumed.121.262543
You have access
Preclinical Pharmacokinetics and Dosimetry Studies of ¹²⁴I/¹³¹I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models
Ian R. Marsh, Joseph Grudzinski, Dana C. Baiu, Abigail Besemer, Reinier Hernandez, Justin J. Jeffery, Jamey P. Weichert, Mario Otto and Bryan P. Bednarz

Journal of Nuclear Medicine October 1, 2019, 60 (10) 1414-1420; DOI: https://doi.org/10.2967/jnumed.118.225409
You have access
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of ²²³Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Sarah J. Chittenden, Cecilia Hindorf, Christopher C. Parker, Valerie J. Lewington, Brenda E. Pratt, Bernadette Johnson and Glenn D. Flux

Journal of Nuclear Medicine September 1, 2015, 56 (9) 1304-1309; DOI: https://doi.org/10.2967/jnumed.115.157123

Main menu

User menu

Search

molecular radiotherapy